Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson’s Disease
American Chemical Society; doi.org/10.1021/acschemneuro.1c00144
Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
Acta Neuropathologica Communications; doi: 10.1186/s40478-021-01175-w
Structure-Guided Design, Synthesis, and Evaluation of 1-Indanone and 1,3-Indandione Derivatives as Ligands for Misfolded α-Synuclein Aggregates
ChemRxiv; DOI: 10.26434/chemrxiv.13817243.v1
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease
Acta Neuropathologica Communications; https://doi.org/10.1186/s40478-020-01117-y
Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain-derived α-synuclein
Journal of Neuroscience Research; https://doi.org/10.1002/jnr.24782
Sex- and age‐dependent alterations of splenic immune cell profile and NK cell phenotypes and function in C57BL/6J mice
Immunity & Aging; https://doi.org/10.1186/s12979-021-00214-3
TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
Neuroimmunology & Neuroinflammation; https://doi.org/10.1212/NXI.0000000000000937
Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
JAMA Neurology; doi:10.1001/jamaneurol.2020.3311
α-Synuclein promotes IAPP fibril formation in vitro and β-cell amyloid formation in vivo in mice.
Scientific Reports; https://doi.org/10.1038/s41598-020-77409-z.
Criticality as a measure of developing proteinopathy in engineered human neural networks.
bioRxiv; doi: https://doi.org/10.1101/2020.05.03.074666.